Form 8-K - Current report:
SEC Accession No. 0001104659-20-123600
Filing Date
2020-11-10
Accepted
2020-11-10 16:20:30
Documents
3
Period of Report
2020-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2035366d1_8k.htm 8-K 21702
2 EXHIBIT 99.1 tm2035366d1_ex99-1.htm EX-99.1 93420
3 GRAPHIC image_001.jpg GRAPHIC 2517
  Complete submission text file 0001104659-20-123600.txt   119855
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38365 | Film No.: 201301384
SIC: 2834 Pharmaceutical Preparations